Scientific Publications

The landmark research of BostonGene underscores the importance of combining innovative multi-platform analytics with cutting-edge software to improve patient outcomes. Explore our scientific publications to learn more.

Tumor immunity portrait: An AI-driven molecular predictor combining tumor microenvironment and tumor mutational burden for immune checkpoint inhibitor response prediction
Journal of Clinical Oncology, 2023
RNA sequencing as a confirmatory assay and its impact on patient care in multiple cancer types
Journal of Clinical Oncology, 2023
Genomic characterization of the GATA3 mutational landscape in breast cancer
Journal of Clinical Oncology, 2023
Differential genomic and transcriptomic analysis of invasive lobular and ductal carcinomas
Journal of Clinical Oncology, 2023
Novel genomic alterations and transcriptomic-based tumor microenvironment classification of sarcoma and their impact on treatment decision making
Journal of Clinical Oncology, 2023
Aggregated analysis of 1,000 patients with cancer to assess the benefits of integrated whole exome and whole transcriptome sequencing
Journal of Clinical Oncology, 2023
Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1 Inhibitor
Anticancer Research, 2023
B Cell Infiltrate in the Tumor Microenvironment is Associated with Improved Survival in Resected Lung Adenocarcinoma
JTO Clinical and Research Reports, 2023
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL
Blood, 2023
Development and refinement of functional gene expression signatures as a computational tool for comprehensive characterization of transcriptomic data
Cancer Research, 2023
Contact us